Institutions in Washington received $1.32B in NIH funding in fiscal year 2026 across 1,790 awards, #9 among states. University of Washington received the most, $570.1M, and the NIAID was the largest funding institute.
| Rank | Institution | Awards | NIH funding |
|---|---|---|---|
| 1 | University of Washington | 1,000 | $570.1M |
| 2 | Fred Hutchinson Cancer Center | 340 | $359.8M |
| 3 | Seattle Children's Hospital | 153 | $107.6M |
| 4 | Allen Institute | 31 | $84.1M |
| 5 | Benaroya Research Institute at Virginia Mason | 43 | $59.8M |
| 6 | Washington State University | 87 | $41.7M |
| 7 | Battelle Pacific Northwest Laboratories | 19 | $19.1M |
| 8 | Institute for Systems Biology | 23 | $14.2M |
| 9 | Sage Bionetworks | 5 | $8.5M |
| 10 | Seattle Institute for Biomedical/Clinical Research | 13 | $8.1M |
| 11 | Bloodworks | 4 | $2.7M |
| 12 | Swedish Medical Center, First Hill | 1 | $2.6M |
| 13 | Virtici, Llc | 6 | $2.4M |
| 14 | Kinea Bio, Inc. | 3 | $2.4M |
| 15 | Pacific Northwest Research Institute | 3 | $2.4M |
| 16 | Healing Lodge of the Seven Nations | 6 | $2.2M |
| 17 | Providence Health & Services - Oregon | 4 | $2.1M |
| 18 | Syntrix Biosystems, Inc. | 3 | $1.7M |
| 19 | Western Washington University | 3 | $1.5M |
| 20 | Patchclamp Medtech, Inc. | 1 | $1.5M |
| 21 | Epicure Therapeutics, Inc. | 1 | $1.5M |
| 22 | Orlance, Inc. | 2 | $1.3M |
| 23 | Inbios International, Inc. | 2 | $1.3M |
| 24 | Cytoterra Inc. | 2 | $1.3M |
| 25 | Glyciome, Llc | 1 | $1.2M |
| Institute | Focus | Funding |
|---|---|---|
| NIAID | infectious disease, immunology and allergy | $343.0M |
| NCI | cancer | $213.2M |
| NIA | aging and Alzheimer's disease | $99.9M |
| NHLBI | heart, lung, blood and sleep | $91.3M |
| NIMH | mental health | $74.3M |
| NIGMS | basic biomedical science and research training | $71.3M |
| NICHD | child health, pregnancy and development | $70.9M |
| NIDDK | diabetes, digestive and kidney disease | $64.4M |
| NINDS | neurology and stroke | $56.0M |
| NIDA | addiction and substance use | $50.8M |
NIH awards to Washington institutions moved from $1.36B in fiscal year 2025 to $1.32B in 2026, a change of -2.9% against -0.3% nationally.
| Institution | FY2025 | FY2026 | Change |
|---|---|---|---|
| Fred Hutchinson Cancer Center | $398.8M | $359.8M | -9.8% |
| Allen Institute | $95.5M | $84.1M | -12.0% |
| Seattle Children's Hospital | $116.2M | $107.6M | -7.4% |
| Seattle Institute for Biomedical/Clinical Research | $10.9M | $8.1M | -26.3% |
| Quant, Inc. | $1.8M | $652K | -64.5% |
| Washington State University | $31.2M | $41.7M | +33.8% |
| Battelle Pacific Northwest Laboratories | $9.6M | $19.1M | +99.0% |
| Benaroya Research Institute at Virginia Mason | $51.0M | $59.8M | +17.3% |
| University of Washington | $563.7M | $570.1M | +1.1% |
| Providence Health & Services - Oregon | $975K | $2.1M | +118.3% |
Largest decreases first, then largest increases. Every state compared.
See Washington university research spending (all sources, NSF HERD) and every federal funder.
Washington is #9 on NIH funding by state.